Snowden Capital Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $235K | Buy |
939
+41
| +5% | +$10.2K | 0.01% | 1132 |
|
|
2025
Q4 | $247K | Sell |
898
-92
| -9% | -$25.2K | 0.01% | 1126 |
|
|
2025
Q3 | $260K | Sell |
990
-18
| -2% | -$4.38K | 0.01% | 1080 |
|
|
2025
Q2 | $221K | Buy |
1,008
+32
| +3% | +$6.84K | 0.01% | 1136 |
|
|
2025
Q1 | $219K | Buy |
976
+129
| +15% | +$35.6K | 0.01% | 1124 |
|
|
2024
Q4 | $278K | Sell |
847
-22
| -3% | -$6.92K | 0.01% | 1023 |
|
|
2024
Q3 | $261K | Sell |
869
-68
| -7% | -$20.8K | 0.01% | 1070 |
|
|
2024
Q2 | $309K | Sell |
937
-8,232
| -90% | -$2.91M | 0.01% | 959 |
|
|
2024
Q1 | $3.63M | Buy |
9,169
+1,510
| +20% | +$559K | 0.11% | 222 |
|
|
2023
Q4 | $2.7M | Sell |
7,659
-1,623
| -17% | -$574K | 0.1% | 236 |
|
|
2023
Q3 | $3.48M | Sell |
9,282
-30
| -0.3% | -$11.6K | 0.15% | 195 |
|
|
2023
Q2 | $3.56M | Buy |
9,312
+8,145
| +698% | +$2.91M | 0.13% | 209 |
|
|
2023
Q1 | $404K | Buy |
1,167
+112
| +11% | +$32.7K | 0.02% | 823 |
|
|
2022
Q4 | $248K | Sell |
1,055
-453
| -30% | -$107K | 0.01% | 996 |
|
|
2022
Q3 | $371K | Sell |
1,508
-189
| -11% | -$57.6K | 0.02% | 791 |
|
|
2022
Q2 | $513K | Sell |
1,697
-34
| -2% | -$11.1K | 0.02% | 619 |
|
|
2022
Q1 | $711K | Buy |
1,731
+515
| +42% | +$202K | 0.03% | 524 |
|
|
2021
Q4 | $570K | Sell |
1,216
-381
| -24% | -$164K | 0.03% | 432 |
|
|
2021
Q3 | $678K | Sell |
1,597
-35
| -2% | -$14.8K | 0.03% | 456 |
|
|
2021
Q2 | $586K | Buy |
1,632
+492
| +43% | +$163K | 0.03% | 500 |
|
|
2021
Q1 | $321K | Buy |
+1,140
| New | +$326K | 0.02% | 605 |
|
|
2020
Q4 | – | Sell |
-959
| Closed | -$264K | – | 688 |
|
|
2020
Q3 | $264K | Buy |
+959
| New | +$254K | 0.02% | 493 |
|
Other funds holding WST
VCM
VPM
GIM
